Work for a Member company and need a Member Portal account? Register here with your company email address.

Article

DeepCure scores $40M for AI-enabled drug discovery

poba/Getty Images

Nov. 9, 2021

By Emily Olsen

DeepCure, developer of small molecule therapeutics using an AI-enabled drug discovery platform, raised $40 million in Series A funding.

The round was led by Morningside Ventures with participation from existing investors TLV Partners, Sapir Venture Partners and Benon Group Ltd.

DeepCure said the Series A brings its total raise to $47 million.

Read on MobiHealthNews

Exploration of Methods for Many-Site Genome Editing with MAGE

Sterling, B. "Exploration of Methods for Many-Site Genome Editing with MAGE"

LocationMIT Media Lab, Room TBA DescriptionThis workshop plans to discuss the technology behind printed electronics and how it is poised to…

Professor Jacobson was recognized for his work developing electronic ink.

The screen technology used in e-readers like the Amazon Kindle was conceived by undergraduates at MIT.